WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsValueAct Capital › Q3 2010

ValueAct Capital 13F holdings, Q3 2010

Holdings as of September 30, 2010 · filings on SEC EDGAR · latest filing →

ValueAct Capital disclosed 12 US equity positions worth $3.2bn in its Q3 2010 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 21.0% of the reported book, followed by IT and SARA LEE CORP. Against the Q2 2010 filing, it opened 3 new positions, added to 5 and reduced 1 among the top 12 holdings.

← Q2 2010 · Q4 2010 →

What did ValueAct Capital own in Q3 2010? Top 12 positions

#StockSectorWeightValueSharesΔ sharesvs Q2 2010
1 VALEANT PHARMACEUTICALS INTL 21.0%$675.3m26,959,901 78% added
2 IT GARTNER GROUP INC NEW-CL A Technology 15.4%$494.3m16,790,013 -19% reduced
3 SARA LEE CORP 14.6%$469.0m34,918,822 0% held
4 VRSN VERISIGN INC Technology 11.7%$375.6m11,832,069 4% added
5 C R BARD INC 10.8%$345.8m4,246,844 44% added
6 WILLIS GROUP HOLDINGS PUBLIC 8.3%$266.8m8,656,910 12% added
7 SNA SNAP ON TOOLS CORP Industrials 6.7%$215.1m4,625,395 27% added
8 ALERE INC 5.0%$161.7m5,228,282 new
9 IMMUCOR INC 4.7%$149.5m7,540,665 0% held
10 OPLN KAR AUCTION SERVICES INC Consumer Cyclical 0.9%$28.5m2,258,828 0% held
11 POLYCOM INC 0.6%$17.7m650,000 new
12 ALERE INC PERP 0.3%$10.8m48,994 new

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.